The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01295827
Brief Title: Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) (KEYNOTE-001)

First Submitted : February 10, 2011
First Submitted that Met QC Criteria : February 14, 2011
First Posted : February 15, 2011 (Estimate)

Results First Submitted : October 21, 2019
Results First Submitted that Met QC Criteria : November 22, 2019
Results First Posted : December 13, 2019

Last Update Submitted that Met QC Criteria : November 22, 2019
Last Update Posted : December 13, 2019